Current role
Yale Podnos
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Yale Podnos
The proxy statement of Starling Oncology, Inc. reports total compensation of $775,905 for Yale Podnos in fiscal 2025, including a base salary of $447,000. Disclosed compensation is on record for 4 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Starling Oncology, Inc. (STLN)
Proxy statement
CurrentStart not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Starling Oncology, Inc.
Other people whose current roles at this company are on record from its filings.
- Daniel Virnich CEO, COO, Board Member
- Anne McGeorge Chairman
- Brad Hively Chairman
- Robert Carter CFO, Chief Accounting Officer
- Dr. Matt Miller COO
- Jeremy N. Castle COO
- Mark Huppelsheuser General Counsel
- Dr. Gregory Sorensen Board Member
- Dr. Jennifer Carter Board Member
- Dr. Mohit Kaushal Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Starling Oncology, Inc. (STLN) | — | $447,000 | $775,905 |
| 2024 | Starling Oncology, Inc. (STLN) | — | $407,000 | $610,332 |
| 2023 | Starling Oncology, Inc. (STLN) | — | $395,000 | $591,284 |
| 2022 | Starling Oncology, Inc. (STLN) | — | $383,050 | $1,249,186 |
Recent activity
No call appearances or filed executive changes recorded yet.